A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
Clinical trial NCT03958890 · UNKNOWN
Trial details
- NCT number
- NCT03958890
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-19
- Primary completion
- 2023-04-30
- Enrollment
- 489
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.